Sponsor or institution
Clinical trials and research at Ascletis Pharma Inc
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Ascletis Pharma Inc that are recruiting, at sites in 7 countries (most in United States (5), Czechia (2), Germany (2)). 2 were first registered in the last 30 days. By phase: Phase 1 (3), Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2New in 30 days
- 7Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ASC36 tablets in adults with obesity or overweight | Phase 1 | South Miami, Florida | Recruiting | Oct 23, 2026 |
| Two ASC36 injections in adults with obesity or overweight | Phase 1 | San Antonio, Texas and 1 other locations | Recruiting | Oct 23, 2026 |
| ASC35 Injection in People with Overweight or Obesity | Phase 1 | Baltimore, Maryland | Recruiting | Sep 25, 2026 |
| Once-daily ASC30 for adults who are overweight or obese with weight-related health issues | Phase 3 | Birmingham, Alabama and 121 other locations | Recruiting | Aug 3, 2026 |
| Once-daily ASC30 to See if it helps adults with obesity or overweight and Type 2 diabetes | Phase 3 | Birmingham, Alabama and 134 other locations | Recruiting | Aug 3, 2026 |
All recruiting trials (5)
-
ASC36 tablets in adults with obesity or overweight
A small study will test ASC36 tablets to see if they are safe and tolerated in adults with obesity or overweight, compared to placebo.
-
Two ASC36 injections in adults with obesity or overweight
A small early study tests two ASC36 injections and their placebos to see if they are safe and how they behave in the body for adults with obesity or overweight.
-
ASC35 Injection in People with Overweight or Obesity
This study tests ASC35 injections to see if they are safe and well tolerated in adults with overweight or obesity.
-
Once-daily ASC30 for adults who are overweight or obese with weight-related health issues
This study tests whether three different daily doses of ASC30 can help adults who are overweight or obese with related health problems lose weight and stay safe.
-
Once-daily ASC30 to See if it helps adults with obesity or overweight and Type 2 diabetes
This study tests three daily doses of ASC30 against placebo in adults who are overweight or obese and have Type 2 diabetes to see if it helps with weight loss and safety over time.
Quick answers
How many clinical trials run by Ascletis Pharma Inc are recruiting right now?
5, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (5 trials), Czechia (2 trials), Germany (2 trials), Greece (2 trials), Poland (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 3, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.